Cytoplasmic Domain of Influenza B Virus BM2 Protein Plays Critical Roles in Production of Infectious VirusIMAI, Masaki; KAWASAKI, Kazunori; ODAGIRI, Takato et al.Journal of virology. 2008, Vol 82, Num 2, pp 728-739, issn 0022-538X, 12 p.Article

Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse modelNINOMIYA, Ai; IMAI, Masaki; TASHIRO, Masato et al.Vaccine. 2007, Vol 25, Num 18, pp 3554-3560, issn 0264-410X, 7 p.Article

Influenza B virus BM2 protein is a crucial component for incorporation of viral ribonucleoprotein complex into virions during virus assemblyIMAI, Masaki; WATANABE, Shinji; NINOMIYA, Ai et al.Journal of virology. 2004, Vol 78, Num 20, pp 11007-11015, issn 0022-538X, 9 p.Article

Antiviral effects of Psidium guajava Linn. (guava) tea on the growth of clinical isolated H1 N1 viruses: Its role in viral hemagglutination and neuraminidase inhibitionSRIWILAIJAROEN, Nongluk; FUKUMOTO, Syuichi; KUMAGAI, Kenji et al.Antiviral research. 2012, Vol 94, Num 2, pp 139-146, issn 0166-3542, 8 p.Article

Development of H5-RT-LAMP (loop-mediated isothermal amplification) system for rapid diagnosis of H5 avian influenza virus infectionIMAI, Masaki; NINOMIYA, Ai; MINEKAWA, Harumi et al.Vaccine. 2006, Vol 24, Num 44-46, pp 6679-6682, issn 0264-410X, 4 p.Article

Characterization of Neutralizing Antibodies in Adults After Intranasal Vaccination With an Inactivated Influenza VaccineAINAI, Akira; TAMURA, Shin-Ichi; ODAGIRI, Takato et al.Journal of medical virology. 2012, Vol 84, Num 2, pp 336-344, issn 0146-6615, 9 p.Article

The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolateHORIMOTO, Taisuke; TAKADA, Ayato; ITO, Hirotoshi et al.Vaccine. 2006, Vol 24, Num 17, pp 3669-3676, issn 0264-410X, 8 p.Article

A prime―boost vaccination of mice with heterologous H5N1 strainsIKENO, Daisuke; KIMACHI, Kazuhiko; KUDO, Yasuhiro et al.Vaccine. 2009, Vol 27, Num 23, pp 3121-3125, issn 0264-410X, 5 p.Article

The Global Circulation of Seasonal Influenza A (H3N2) VirusesRUSSELL, Colin A; JONES, Terry C; DE JONG, Jan C et al.Science (Washington, D.C.). 2008, Vol 320, Num 5874, pp 340-346, issn 0036-8075, 7 p.Article

Timely production of A/Fujian-like influenza vaccine matching the 2003-2004 epidemic strain may have been possible using Madin-Darby canine kidney cellsMAKIZUMI, Keiichi; KIMACHI, Kazuhiko; FUKADA, Katsuhiko et al.Vaccine. 2008, Vol 26, Num 52, pp 6852-6858, issn 0264-410X, 7 p.Article

Rapid diagnosis of H5N1 avian influenza virus infection by newly developed influenza H5 hemagglutinin gene-specific loop-mediated isothermal amplification methodIMAI, Masaki; NINOMIYA, Ai; MINEKAWA, Harumi et al.Journal of virological methods. 2007, Vol 141, Num 2, pp 173-180, issn 0166-0934, 8 p.Article

WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013BARR, Ian G; RUSSELL, Colin; MCCAULEY, John et al.Vaccine. 2014, Vol 32, Num 37, pp 4713-4725, issn 0264-410X, 13 p.Article

Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in miceHARADA, Yuichi; NINOMIYA-MORI, Ai; TAKAHASHI, Yoshimasa et al.Vaccine. 2011, Vol 29, Num 46, pp 8330-8337, issn 0264-410X, 8 p.Article

Mumefural and related HMF derivatives from Japanese apricot fruit juice concentrate show multiple inhibitory effects on pandemic influenza A (H1N1) virusSRIWILAIJAROEN, Nongluk; KADOWAKI, Akio; ONISHI, Yuriko et al.Food chemistry. 2011, Vol 127, Num 1, pp 1-9, issn 0308-8146, 9 p.Article

Induction of Cross-Protective Immunity Against Influenza A Virus H5N1 by an Intranasal Vaccine With Extracts of Mushroom MyceliaICHINOHE, Takeshi; AINAI, Akira; CHIBA, Joe et al.Journal of medical virology. 2010, Vol 82, Num 1, pp 128-137, issn 0146-6615, 10 p.Article

An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusionGOPINATH, Subash C. B; MISONO, Tomoko S; KAWASAKI, Kazunori et al.Journal of general virology. 2006, Vol 87, pp 479-487, issn 0022-1317, 9 p., 3Article

Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomideIWAI, Yuma; TAKAHASHI, Hitoshi; TASHIRO, Masato et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 14, pp 5379-5390, issn 0968-0896, 12 p.Article

Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virusICHINOHE, Takeshi; NAGATA, Noriyo; CHIBA, Joe et al.Journal of medical virology. 2007, Vol 79, Num 6, pp 811-819, issn 0146-6615, 9 p.Article

Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptationSAITO, Takehiko; NAKAYA, Yoko; USUI, Taichi et al.Journal of medical virology. 2004, Vol 74, Num 2, pp 336-343, issn 0146-6615, 8 p.Article

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013MEIJER, Adam; REBELO-DE-ANDRADE, Helena; LO, Janice et al.Antiviral research. 2014, Vol 110, pp 31-41, issn 0166-3542, 11 p.Article

Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009―2010 Northern Hemisphere seasonBARR, Ian G; MCCAULEY, John; ODAGIRI, Takato et al.Vaccine. 2010, Vol 28, Num 5, pp 1156-1167, issn 0264-410X, 12 p.Article

Protective Immunity Afforded by Inactivated H5N1 (NIBRG-14) Vaccine Requires Antibodies against Both Hemagglutinin and Neuraminidase in MiceTAKAHASHI, Yoshimasa; HASEGAWA, Hideki; HARA, Yukari et al.The Journal of infectious diseases. 2009, Vol 199, Num 11, pp 1629-1637, issn 0022-1899, 9 p.Article

Differences in the priming effect of various clades/subclades of inactivated H5N1 vaccine for booster injection with heterologous clades of vaccine strainsIKENO, Daisuke; KIMACHI, Kazuhiko; IBARAGI, Kayo et al.Vaccine. 2011, Vol 29, Num 24, pp 4156-4161, issn 0264-410X, 6 p.Article

Rapid Discrimination of Oseltamivir-Resistant 275Y and -Susceptible 275H Substitutions in the Neuraminidase Gene of Pandemic Influenza A/H1N1 2009 Virus by Duplex One-Step RT-PCR AssayNAKAUCHI, Mina; UJIKE, Makoto; KAGEYAMA, Tsutomu et al.Journal of medical virology. 2011, Vol 83, Num 7, pp 1121-1127, issn 0146-6615, 7 p.Article

Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza virusesRUSSELL, Colin A; JONES, Terry C; DE JONG, Jan C et al.Vaccine. Supplement. 2008, Vol 26, Num 4, issn 1359-5938, D31-D34Article